SIGNIFIER MEDICAL TECHNOLOGIES LIMITEDActive
Key figures
Amounts are in USD (the currency of the accounts).
SIGNIFIER MEDICAL TECHNOLOGIES LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2024/25 | |
|---|---|---|
| Profit for the year | — | -4,139,023 |
| Cash at bank and in hand | 1,575,955 | — |
| Total assets | 9,650,848 | 33,999,931 |
| Total liabilities | — | — |
| Net assets / total equity | 8,909,038 | 9,052,806 |
| Average number of employees | 10 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activities of the Group and Company during the year involved the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions.
As described in the company's latest filed accounts.
Summary: SIGNIFIER MEDICAL TECHNOLOGIES LIMITED
Company
SIGNIFIER MEDICAL TECHNOLOGIES LIMITED is a private limited company registered with Companies House under company number 09455560. It was incorporated on 24 Feb 2015. Its status is active. The registered office is in Ashford (TN23). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Loss for the year was 4,139,023 USD. Net assets were 9,052,806 USD, up 1.6% on the previous year. The company had an average of 0 employees. Figures are available for 2 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 14 Jan 2027.